These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 362141)

  • 21. Rubella: immunity and vaccination in schoolgirls.
    Kudesia G; Robinson ET; Wilson WD; Wilson TS; Stewart IM; Campbell AT; Thomson W; Silver M; Reid D; Urquhart GE
    Br Med J (Clin Res Ed); 1985 May; 290(6479):1406-8. PubMed ID: 3922513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trials with a live attenuated rubella virus vaccine, Cendehill strain.
    Grant L; Belle EA; Provan G; King SD; Sigel MM
    J Hyg (Lond); 1970 Sep; 68(3):505-10. PubMed ID: 5272349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal administration of RA 27/3 rubella virus vaccine. A clinical trial in young adults.
    Paradise JE; Nemorofsky D; Huggins GR; Sondheimer SJ; Plotkin SA
    J Adolesc Health Care; 1984 Apr; 5(2):75-8. PubMed ID: 6368506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-partum rubella immunisation: a controlled trial of two vaccines.
    Black NA; Parsons A; Kurtz JB; McWhinney N; Lacey A; Mayon-White RT
    Lancet; 1983 Oct; 2(8357):990-2. PubMed ID: 6138593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination with a live RA 27/3 strain rubella vaccine (Rudivax), a follow-up study.
    Suni JI; Meurman O; Hirvonen P; Vaheri A
    Vaccine; 1984 Dec; 2(4):281-3. PubMed ID: 6531969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trial of high-titre human rubella immunoglobulin.
    Urquhart GE; Crawford RJ; Wallace J
    Br Med J; 1978 Nov; 2(6148):1331-2. PubMed ID: 363233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunoglobulin M response to rubella vaccine in young adult women.
    Mortimer PP; Edwards JM; Porter AD; Tedder RS; Haslehurst J
    J Hyg (Lond); 1984 Jun; 92(3):277-83. PubMed ID: 6376624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a vaccination programme on the distribution of rubella antibodies in women of childbearing age.
    Hambling MH
    Lancet; 1975 May; 1(7916):1130-3. PubMed ID: 49484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rubella vaccination: persistence of antibodies for up to 16 years.
    O'Shea S; Best JM; Banatvala JE; Marshall WC; Dudgeon JA
    Br Med J (Clin Res Ed); 1982 Jul; 285(6337):253-5. PubMed ID: 6807437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of congenital rubella and results of rubella vaccination in Australia.
    Menser MA; Hudson JR; Murphy AM; Upfold LJ
    Rev Infect Dis; 1985; 7 Suppl 1():S37-41. PubMed ID: 3890106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late seroconversion following HPV-77, DE5 rubella virus vaccine.
    Wilkins J
    Am J Obstet Gynecol; 1975 Apr; 121(7):998-1002. PubMed ID: 1115189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of low level immunity on response to live rubella virus vaccine.
    Väänänen P; Mäkelä P; Vaheri A
    Vaccine; 1986 Mar; 4(1):5-8. PubMed ID: 3962450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions].
    Nakazono N
    Hokkaido Igaku Zasshi; 1984 Mar; 59(2):180-91. PubMed ID: 6745839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duration of immunity after rubella vaccination: a long-term study in Switzerland.
    Just M; Just V; Berger R; Burkhardt F; Schilt U
    Rev Infect Dis; 1985; 7 Suppl 1():S91-4. PubMed ID: 4001742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence of antibody induced by rubella vaccine (Wistar RA 27/3 strain) after six years.
    Hillary IB; Freestone DS
    J Hyg (Lond); 1975 Dec; 75(3):407-11. PubMed ID: 1059708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination against rubella in Britain: benefits and risks.
    Freestone DS
    Dev Biol Stand; 1979; 43():339-48. PubMed ID: 520680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characterization of antirubella vaccine in an epidemiological trial].
    Popov VF; Iunasova TN; Gaĭderova LA; Aksenov LA; Averina OB; Shitikova OIu
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (6):41-3. PubMed ID: 15636138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Improvement of rubella vaccination. Seroconversion after serial rubella vaccination with the jet injector].
    Weber HG; Willers H
    Fortschr Med; 1982 Jun; 100(24):1161-3. PubMed ID: 7106679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rubella vaccination: antibody persistence for 14-17 years and immune status of women without and with a history of vaccination].
    Enders G; Nickerl U
    Immun Infekt; 1988 Apr; 16(2):58-64. PubMed ID: 3391631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team.
    Ray P; Black S; Shinefield H; Dillon A; Schwalbe J; Holmes S; Hadler S; Chen R; Cochi S; Wassilak S
    JAMA; 1997 Aug; 278(7):551-6. PubMed ID: 9268275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.